1. Soubise, Benoît, Jiang, Yan, Douet-Guilbert, Nathalie, Troadec, Marie-Bérengère. 2022. RBM22, a Key Player of Pre-mRNA Splicing and Gene Expression Regulation, Is Altered in Cancer. In Cancers, 14, . doi:10.3390/cancers14030643. https://pubmed.ncbi.nlm.nih.gov/35158909/
2. Jiménez-Vacas, Juan M, Montero-Hidalgo, Antonio J, Gómez-Gómez, Enrique, Gahete, Manuel D, Luque, Raul M. 2022. Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes. In Translational research : the journal of laboratory and clinical medicine, 253, 68-79. doi:10.1016/j.trsl.2022.08.016. https://pubmed.ncbi.nlm.nih.gov/36089245/
3. Hou, Min, Huang, Qingmei, Chen, Shan, Lei, Jing, Zhang, Yakun. 2024. RNA binding protein RBM22 suppresses non-small cell lung cancer tumorigenesis by stabilizing LATS1 mRNA. In Journal of molecular histology, 56, 15. doi:10.1007/s10735-024-10285-3. https://pubmed.ncbi.nlm.nih.gov/39612045/
4. Fuentes-Fayos, Antonio C, Vázquez-Borrego, Mari C, Jiménez-Vacas, Juan M, Castaño, Justo P, Luque, Raúl M. . Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3. In Brain : a journal of neurology, 143, 3273-3293. doi:10.1093/brain/awaa273. https://pubmed.ncbi.nlm.nih.gov/33141183/
5. Douet-Guilbert, Nathalie, Soubise, Benoît, Bernard, Delphine G, Troadec, Marie-Bérengère. 2022. Cytogenetic and Genetic Abnormalities with Diagnostic Value in Myelodysplastic Syndromes (MDS): Focus on the Pre-Messenger RNA Splicing Process. In Diagnostics (Basel, Switzerland), 12, . doi:10.3390/diagnostics12071658. https://pubmed.ncbi.nlm.nih.gov/35885562/
6. He, F, Wang, C-T, Gou, L-T. 2009. RNA-binding motif protein RBM22 is required for normal development of zebrafish embryos. In Genetics and molecular research : GMR, 8, 1466-73. doi:10.4238/vol8-4gmr683. https://pubmed.ncbi.nlm.nih.gov/20013661/
7. Boultwood, Jacqueline, Pellagatti, Andrea, Cattan, Helen, Hellström-Lindberg, Eva, Wainscoat, James S. 2007. Gene expression profiling of CD34+ cells in patients with the 5q- syndrome. In British journal of haematology, 139, 578-89. doi:. https://pubmed.ncbi.nlm.nih.gov/17916100/